Sinobiopharma’s production facility for solid dosage Perindopril has passed Chinese State Food and Drug Administration (SFDA) inspection and is now approved for production and marketing. The company received SFDA approval for its formulation of Perindopril in April 2009. SFDA regulations require that drug makers conduct large-scale production of at least three batches of a newly approved drug in a GMP certified production facility. SFDA officials inspect the production process, the applicatio...